Molecular pharming's foot in the FDA's door: Protalix's trailblazing story.
- Published in:
- Biotechnology Letters, 2015, v. 37, n. 11, p. 2147, doi. 10.1007/s10529-015-1908-z
- By:
- Publication type:
- Article
Works matching DE "PROTALIX BioTherapeutics Inc."
Results: 5
1
2
Drugmaker reaps what it sows with first plant-made biologic.
- Published in:
- Nature Medicine, 2012, v. 18, n. 1, p. 5, doi. 10.1038/nm0112-5
- By:
- Publication type:
- Article
3
Drug-making plant blooms.
- Published in:
- Nature, 2012, v. 485, n. 7397, p. 160, doi. 10.1038/485160a
- By:
- Publication type:
- Article
4
Shire submits European marketing authorization application for velaglucerase a for the treatment of type 1 Gaucher's Disease.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2010, v. 5, n. 1, p. 4
- Publication type:
- Article
5
Pfizer stakes a claim in plant cell–made biopharmaceuticals.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 2, p. 107, doi. 10.1038/nbt0210-107
- By:
- Publication type:
- Article